The effect of restriction of fluid in treatment of transient tachypnea of newborn

The effect of limitation of fluid in treatment of transient tachypnea of newborn

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015122225650N1

Enrollment

Registered

2016-03-07

Start date

2015-10-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Transient tachypnea of newborn. Transient tachypnea of newborn

Interventions

Intervention 1: Intervention group:reception of fluid 50cc/kg/d. Intervention 2: Control group:reception of fluid 65 cc/kg/d.

Intervention group:reception of fluid 50cc/kg/d

Control group:reception of fluid 65 cc/kg/d

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: The late preterm (gestational age of 34 – 37 weeks) and term (gestational ageof 37 -42 weeks) and post term (gestational age greater than 42 weeks) neonates with tachypnea (Respiratory Rate greater than 60 per minute) with or without respiratory distress within 6 hours of birth. Exclusion criteria: Pretem neonates (gestational age less than 34 weeks); neonates with history of asphyxia;RDS;air-block syndrom; birth trauma; congenital anomaly and neonates with blood culture positive and also infants who receive surfactants while treatment or develop dehydration complication (weight loss more than one percent daily, reduce urine outflow to lower than (1cc /kg /hour) or increase urine specific gravity more than( 1/017) have excluded from study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Tachypnea. Timepoint: daily. Method of measurement: observation and record of respirtory rate per minute.	—

Secondary

Measure	Time frame
Reduce of hospitalization. Timepoint: date of discharge. Method of measurement: day.;Retraction Score. Timepoint: daily. Method of measurement: Oservation and record on bases of SILVERMAN - ANDERSON Retraction Score.;Respiratory rate. Timepoint: daily. Method of measurement: observation and record of respirtory rate per minute.;Arterial Blood Gases. Timepoint: daily. Method of measurement: Blood sample.;O2 requirement. Timepoint: daily. Method of measurement: per liter. per minute.;Level of respiratory support. Timepoint: daily. Method of measurement: severity.	—

Measure

Time frame

Reduce of hospitalization. Timepoint: date of discharge. Method of measurement: day.;Retraction Score. Timepoint: daily. Method of measurement: Oservation and record on bases of SILVERMAN - ANDERSON Retraction Score.;Respiratory rate. Timepoint: daily. Method of measurement: observation and record of respirtory rate per minute.;Arterial Blood Gases. Timepoint: daily. Method of measurement: Blood sample.;O2 requirement. Timepoint: daily. Method of measurement: per liter. per minute.;Level of respiratory support. Timepoint: daily. Method of measurement: severity.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMitra Gorji Rad

Babol University of Medical Sciences

m.gorjirad@mubabol.ac.ir+98 11 3219 2832

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026